BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 32889653)

  • 1. Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer's Disease.
    Kabir MT; Uddin MS; Zaman S; Begum Y; Ashraf GM; Bin-Jumah MN; Bungau SG; Mousa SA; Abdel-Daim MM
    Mol Neurobiol; 2021 Jan; 58(1):1-20. PubMed ID: 32889653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biometal Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer's Disease.
    Li Y; Jiao Q; Xu H; Du X; Shi L; Jia F; Jiang H
    Front Mol Neurosci; 2017; 10():339. PubMed ID: 29114205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biometals as Potential Predictors of the Neurodegenerative Decline in Alzheimer's Disease.
    Lavado LK; Zhang MH; Patel K; Khan S; Patel UK
    Cureus; 2019 Sep; 11(9):e5573. PubMed ID: 31695992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
    Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
    J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trace concentrations, heavy implications: Influences of biometals on major brain pathologies of Alzheimer's disease.
    Lippi SLP; Neely CLC; Amaya AL
    Int J Biochem Cell Biol; 2022 Feb; 143():106136. PubMed ID: 34906694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradigm shift redefining molecular, metabolic and structural events in Alzheimer's disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration.
    Cavaleri F
    Med Hypotheses; 2015 May; 84(5):460-9. PubMed ID: 25691377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal Ion Effects on Aβ and Tau Aggregation.
    Kim AC; Lim S; Kim YK
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease, metal ions and metal homeostatic therapy.
    Zatta P; Drago D; Bolognin S; Sensi SL
    Trends Pharmacol Sci; 2009 Jul; 30(7):346-55. PubMed ID: 19540003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.
    Wang WT; Tailor BA; Cohen DS; Huang X
    EC Pharmacol Toxicol; 2019 Jul; 7(7):547-558. PubMed ID: 31565701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic treatment of Alzheimer's disease using metal complexing agents.
    Price KA; Crouch PJ; White AR
    Recent Pat CNS Drug Discov; 2007 Nov; 2(3):180-7. PubMed ID: 18221229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress and the pathogenesis of Alzheimer's disease.
    Zhao Y; Zhao B
    Oxid Med Cell Longev; 2013; 2013():316523. PubMed ID: 23983897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease.
    Wang P; Wang ZY
    Ageing Res Rev; 2017 May; 35():265-290. PubMed ID: 27829171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure of metal toxicity in Alzheimer's disease: An extensive review.
    Islam F; Shohag S; Akhter S; Islam MR; Sultana S; Mitra S; Chandran D; Khandaker MU; Ashraf GM; Idris AM; Emran TB; Cavalu S
    Front Pharmacol; 2022; 13():903099. PubMed ID: 36105221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox-active metals, oxidative stress, and Alzheimer's disease pathology.
    Huang X; Moir RD; Tanzi RE; Bush AI; Rogers JT
    Ann N Y Acad Sci; 2004 Mar; 1012():153-63. PubMed ID: 15105262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of metals in Alzheimer's disease.
    Das N; Raymick J; Sarkar S
    Metab Brain Dis; 2021 Oct; 36(7):1627-1639. PubMed ID: 34313926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of neurotoxicants in the pathogenesis of Alzheimer's disease: a mechanistic insight.
    Nisa FY; Rahman MA; Hossen MA; Khan MF; Khan MAN; Majid M; Sultana F; Haque MA
    Ann Med; 2021 Dec; 53(1):1476-1501. PubMed ID: 34433343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current understanding of metal ions in the pathogenesis of Alzheimer's disease.
    Wang L; Yin YL; Liu XZ; Shen P; Zheng YG; Lan XR; Lu CB; Wang JZ
    Transl Neurodegener; 2020; 9():10. PubMed ID: 32266063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal exposure and Alzheimer's pathogenesis.
    Liu G; Huang W; Moir RD; Vanderburg CR; Lai B; Peng Z; Tanzi RE; Rogers JT; Huang X
    J Struct Biol; 2006 Jul; 155(1):45-51. PubMed ID: 16503166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease.
    Nam E; Derrick JS; Lee S; Kang J; Han J; Lee SJC; Chung SW; Lim MH
    ACS Chem Neurosci; 2018 Nov; 9(11):2655-2666. PubMed ID: 29782798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.